Insider · SEC Forms 3, 4, 5
CIK 1494730
All transactions
Every Form 4 row this person reported, newest first
Insider · SEC Forms 3, 4, 5
Every Form 4 row this person reported, newest first
Chan Heng Fai Ambrose (CIK 1261725) reported 20 SEC Form 4 insider transactions across 4 companies over the past 18 months (most recent 2026-09-08). Recent activity: Sell DSS (21,852 shares), Buy HWH (1.5M shares), Buy HWH (320,000 shares), Buy HWH (250,000 shares), Sell HWH (100,390 shares). Source: SEC Form 4.
| Date | Company | Role | Type | Shares | Value |
|---|---|---|---|---|---|
| 2026-09-08 | DSS, INC. (DSS) | Director | Sell | 21,852 | $17,919 |
| 2026-08-11 | HWH International Inc. (HWH) | Chief Executive Officer | Buy | 1.5M | $0 |
| 2026-08-07 | HWH International Inc. (HWH) | Chief Executive Officer | Buy | 320,000 | $0 |
| 2026-06-09 | HWH International Inc. (HWH) | Chief Executive Officer | Buy | 250,000 | $500,000 |
| 2026-04-01 | HWH International Inc. (HWH) | Chief Executive Officer | Sell | 100,390 | $98,382 |
| 2025-12-01 | HWH International Inc. (HWH) | Chief Executive Officer | Buy | 1.0M | $0 |
| 2025-09-16 | Alset Inc. (AEI) | Chief Executive Officer | Sell | 500,000 | $1.3M |
| 2025-09-02 | DSS, INC. (DSS) | Director | Buy | 130,679 | $176,417 |
| 2025-08-19 | Alset Inc. (AEI) | Chief Executive Officer | Buy | 33,000 | $42,570 |
| 2025-07-23 | Alset Inc. (AEI) | Chief Executive Officer | Buy | 27.7M | $0 |
| 2025-07-02 | Alset Inc. (AEI) | Chief Executive Officer | Buy | 280,000 | $0 |
| 2025-04-17 | Alset Inc. (AEI) | Chief Executive Officer | Buy | 1.0M | $0 |
| 2025-04-07 | IMPACT BIOMEDICAL INC. (IBO) | Director | Sell | 351,555 | $175,778 |
| 2025-04-04 | IMPACT BIOMEDICAL INC. (IBO) | Director | Sell | 300,000 | $174,000 |
| 2025-04-04 | IMPACT BIOMEDICAL INC. (IBO) | Director | Sell | 200,000 | $134,000 |
| 2025-04-04 | IMPACT BIOMEDICAL INC. (IBO) | Director | Sell | 2,349 | $1,574 |
| 2025-04-04 | IMPACT BIOMEDICAL INC. (IBO) | Director | Sell | 382,427 | $221,808 |
| 2025-04-04 | IMPACT BIOMEDICAL INC. (IBO) | Director | Sell | 351,631 | $203,946 |
| 2025-04-04 | IMPACT BIOMEDICAL INC. (IBO) | Director | Sell | 273,286 | $213,163 |
| 2025-04-04 | IMPACT BIOMEDICAL INC. (IBO) | Director | Sell | 180,000 | $172,800 |
Source: SEC Form 4 filings · as of 2026-09-08